Adrian Rawcliffe - 08 Dec 2025 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role
Director
Signature
/s/ Adrian Rawcliffe
Issuer symbol
WVE
Transactions as of
08 Dec 2025
Net transactions value
-$379,260
Form type
4
Filing time
10 Dec 2025, 21:45:16 UTC
Previous filing
14 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rawcliffe Adrian Director C/O WAVE LIFE SCIENCES LTD.,, 733 CONCORD AVE., CAMBRIDGE /s/ Adrian Rawcliffe 10 Dec 2025 0001555851

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WVE Ordinary Shares Options Exercise $250,740 +42,000 +331% $5.97 54,700 08 Dec 2025 Direct F1
transaction WVE Ordinary Shares Sale $630,000 -42,000 -77% $15.00 12,700 08 Dec 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WVE Share Option (right to buy) Options Exercise $0 -42,000 -100% $0.000000 0 08 Dec 2025 Ordinary Shares 42,000 $5.97 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2025.
F2 These share options are fully vested.